Ontology highlight
ABSTRACT: Background
Gemcitabine resistance (GR) is a significant clinical challenge in pancreatic adenocarcinoma (PAAD) treatment. Macrophages in the tumor immune-microenvironment are closely related to GR. Uncovering the macrophage-induced GR mechanism could help devise a novel strategy to improve gemcitabine treatment outcomes in PAAD. Therefore, preclinical models accurately replicating patient tumor properties are essential for cancer research and drug development. Patient-derived organoids (PDOs) represent a promising in vitro model for investigating tumor targets, accelerating drug development, and enabling personalized treatment strategies to improve patient outcomes.Methods
To investigate the effects of macrophage stimulation on GR, co-cultures were set up using PDOs from th
SUBMITTER: Jiang S
PROVIDER: S-EPMC10411021 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature